Scarica l'app Stockscreener
3.68
2.79%
0.10
Precedente Chiudi:
$3.58
Aprire:
$3.67
Volume 24 ore:
389.65K
Relative Volume:
0.52
Capitalizzazione di mercato:
$48.96M
Reddito:
$128.60K
Utile/perdita netta:
$-4.60M
Rapporto P/E:
-5.8413
EPS:
-0.63
Flusso di cassa netto:
$-3.74M
1 W Prestazione:
+27.78%
1M Prestazione:
+17.57%
6M Prestazione:
+250.48%
1 anno Prestazione:
+1,010%
Intervallo 1D:
$3.32
$3.80
Intervallo di 1 settimana:
$2.70
$3.87
Portata 52W:
$0.2528
$4.4899
Nexalin Technology Inc Stock (NXL) Company Profile
Nome
Nexalin Technology Inc
Settore
Industria
Telefono
(832) 260-0222
Indirizzo
1776 YORKTOWN, HOUSTON
Confronta NXL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
3.68 | 48.96M | 128.60K | -4.60M | -3.74M | -0.63 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Nexalin Technology Inc Borsa (NXL) Ultime notizie
Nexalin Technology announces effective registration statement - Investing.com
Nexalin technology's chief medical officer buys $3,100 in shares - MSN
Nexalin Technology Inc (NXL) Stock: A Year of Highs and Lows - The InvestChronicle
Nexalin Technology Inc (NXL) Becoming More Attractive for Investors - Knox Daily
Nexalin Technology announces publication of study of DIFS technology - MSN
Can you still get a good price for Nexalin Technology Inc (NXL) Shares at this point? - US Post News
Nexalin technology's chief medical officer buys $2,980 in common stock - MSN
Quoin Pharmaceuticals launches Netherton awareness campaign - MSN
Nexalin’s Breakthrough DIFS™ Neurostimulation Device - GlobeNewswire
Nexalin Technology, Inc. Reports Landmark Study Highlights Efficacy of DIFS™ Technology in Reducing Blood Pressure in Patients with Major Depressive Disorder - Nasdaq
Clinical Trial: New Depression Therapy Achieves Dual Brain and Heart Benefits - StockTitan
Reviewing Nexeon Medsystems (OTCMKTS:NXNN) and Nexalin Technology (NASDAQ:NXL) - Defense World
NXLNexalin Technology, Inc. Latest Stock News & Market Updates - StockTitan
Nexalin technology's chief medical officer buys $4,050 in stock - MSN
Nexalin technology's chief medical officer buys $4,050 in stock By Investing.com - Investing.com Australia
Nexalin technology's chief medical officer buys $7,700 in stock - MSN
Nexalin Technology (NASDAQ:NXL) vs. CeriBell (NASDAQ:CBLL) Head-To-Head Contrast - Defense World
Nexalin technology's chief medical officer buys $7,700 in stock By Investing.com - Investing.com Australia
Nexalin Technology, Inc. Invites Investors to Webinar on Advancements in Neurostimulation and Mental Health Solutions - Nasdaq
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session, Today, January 23 - The Manila Times
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23 - The Bakersfield Californian
Nexalin Tech CEO to Showcase Revolutionary Brain Treatment Device in Exclusive Investor Webinar - StockTitan
Nexalin Technology CEO Mark White Issues Letter to - GlobeNewswire
Nexalin Technology CEO sends letter to shareholders - TipRanks
Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025 - The Manila Times
Nexalin's Revolutionary DIFS Technology Shows 65% Success Rate in Depression Treatment - StockTitan
Head-To-Head Survey: IMRIS (OTCMKTS:IMRSQ) vs. Nexalin Technology (NASDAQ:NXL) - Defense World
Certain Common Stock of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. - Marketscreener.com
Certain Options of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. - Marketscreener.com
Nexalin Technology (NASDAQ:NXL) Shares Up 5.5% – Here’s What Happened - Defense World
How Do Things Look For Nexalin Technology Inc (NASDAQ: NXL) In The Short-Term? - Stocks Register
Nexalin Technology, Inc. Launches Phase 1 of AI-Driven Virtual Clinic to Enhance Mental Health Treatment - Nasdaq
Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic - GlobeNewswire
Nexalin Technology, Inc. Completes Phase 1 of Its Innovative Virtual Clinic - Marketscreener.com
Target Corp (TGT-N) QuotePress Release - The Globe and Mail
Walmart Inc (WMT-N) QuotePress Release - The Globe and Mail
Maxim Group Reaffirms Hold Rating for Nexalin Technology (NASDAQ:NXL) - Defense World
Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities - MSN
Nexalin Technology downgraded to Hold from Buy at Maxim - MSN
Maxim Group Downgrades Nexalin Technology (NXL) - MSN
Nexalin Technology Stock Soars to All-Time High of $4.4 Amidst Stunning Growth - Investing.com Canada
Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World
Nexalin Technology, Inc. (NASDAQ:NXL) Short Interest Update - MarketBeat
Nexalin Technology Inc Azioni (NXL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.14%
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):